2024.09-至今       重庆大学，药学院，副教授

2020.09-2024.08   重庆大学，药学院，弘深青年教师

2017.10-2017.12    南京大学，生命科学学院，药学，博士后

2018.01-2020.06    哥本哈根大学，药理药设学院，药物化学，博士后

2012.09-2017.09    南京大学，生命科学学院，生物学，硕博连读

具有重要药理活性天然产物的理性设计、结构修饰与成药性优化，围绕天然小分子药物高效构建、作用机制解析及新药创制开展系统性研究。

1. 国家自然科学基金面上项目（22577012，主持）

2. 国家自然科学基金青年项目（22101037，主持，结题）

3. 重庆市自然科学基金面上项目（CSTB2025NSCQ-GPX0732，主持）

4. 重庆市人社局项目（2309013457219401，主持）

1. Hanyue Qiu, Xinghai Fei, Jiaojiao Yang, Zhen Qiao, Shan Yuan, Hu Zhang, Ling He, Min Zhang*. A Bischler-Napieralski and homo-Mannich Sequence Enables Diversified Syntheses of Sarpagine Alkaloids and Analogues. Nat. Commun., 2023, 14, 5560.

2. Yankun Zhao, Hongya Yan, Yulian Zhang, Tao Zhou, Mengxing Tian, Chongzhou Zhang, Shan Yuan; Hanyue Qiu*, Ling He, M. Zhang*.Catalytic asymmetric intramolecular propargylation of cyclopropanols to access the cuparane core. Chem. Sci., 2024,15, 10963–10968.

3. Hanyue Qiu, Zhuanzhuan Du, Yankun Zhao, Shan Yuan, Song Xi, Tao Zhou, Jiao Yang, Changhui Zhang, Yang Xiong, Yi Xia, Shaolin Zhang, Lin Fu, Ling He, Min Zhang*. Enantioselective Synthesis and Biological Evaluation of Pyrrolidines Bearing Quaternary Stereogenic Centers. J. Med. Chem., 2023, 66, 14, 9866–9880.

4. Long Guo, Yanjun Zhuge, Liqiang Yang, Hanyue Qiu*, Jin Liu*, Pengfei Wang*. A Two-photon Mitochondria-targeting Azo Reductase Probe for Imaging in Tumor Cells and Mice. Dyes Pigments, 2023, 218, 111512.

5. Shuangwei Liu, Xiaojiao Su, D. Jiang, Hongbing Xiong, Dingyin Miao, Lin Fu, Hanyue Qiu*, Ling He*, Min Zhang*. Arylation of Cyclopropanol with Pyrrole: Asymmetric Synthesis of Indolizidine 167B, Indolizidine 209D, and Monomorine I. Org. Lett., 2023, 25, 2058–2062.

6. Pengfei Wang, Liqiang Yang, Zhaohang Shi, Xuemin Li*, Hanyue Qiu*. An Updated Patent Review of IDO1 Inhibitors for Cancer (2018-2022). Expert Opin. Ther. Pat., 2022, 32, 1145–1159.

7. Song Xi, Yan Jiang, Jiaojiao Yang, Jiao Yang, Dingyin Miao, Baoyi Chen, Wanqiu Huang, Ling He*, Hanyue Qiu*, Min Zhang*. Generation and [2,3]-Sigmatropic Rearrangement of Ammonium Ylides from Cyclopropyl Ketones for Chiral Indolizidines with Bridgehead Quaternary Stereocenters. Org. Lett., 2022, 24, 6957–6961.

8. Hanyue Qiu, Pengfei Wang, Min Zhang*. A Patent Review of mTOR Inhibitors for Cancer Therapy (2011-2020). Expert Opin. Ther. Pat., 2021, 31, 965–975.